| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5504589 | Biochemical and Biophysical Research Communications | 2017 | 7 Pages |
Abstract
The mechanism by which DOPAL modifies GAPDH can serve as a mechanistic explanation to the pathological events in Parkinson's Disease.
Keywords
DOPAC3,4-dihydroxyphenylethanolDOPETDAQALDH2MAODTNBNBTNALGSHGAPDHG3P3,4-dihydroxyphenylacetaldehyde3,4-dihydroxyphenylacetic acid5,5′-dithiobis-(2-nitrobenzoic acid)nitroblue tetrazoliumaldehyde dehydrogenase 2Alpha-synucleinParkinson's diseaseDopaminedopamine quinoneDOPALmonoamine oxidaseGlutathioneglyceraldehyde-3-phosphate dehydrogenase
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Brigitte C. Vanle, Virginia R. Florang, Daryl J. Murry, Arturo L. Aguirre, Jonathan A. Doorn,